ValuEngine cut shares of Molina Healthcare (NYSE:MOH) from a buy rating to a hold rating in a research report released on Thursday.
A number of other brokerages have also recently weighed in on MOH. Piper Jaffray Companies upped their price objective on Molina Healthcare to $165.00 and gave the stock an overweight rating in a research note on Wednesday, September 26th. Morgan Stanley increased their price target on Molina Healthcare from $178.00 to $184.00 and gave the company an overweight rating in a research note on Thursday, October 18th. Zacks Investment Research cut Molina Healthcare from a buy rating to a hold rating in a research note on Monday, October 8th. Evercore ISI began coverage on Molina Healthcare in a research note on Tuesday, October 9th. They issued an in-line rating and a $158.00 price target for the company. Finally, Jefferies Financial Group cut Molina Healthcare from a buy rating to a hold rating and set a $152.00 price target for the company. in a research note on Friday, October 12th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. The company has a consensus rating of Hold and a consensus price target of $130.62.
Shares of NYSE MOH traded up $2.69 during mid-day trading on Thursday, reaching $125.69. 28,605 shares of the company were exchanged, compared to its average volume of 868,611. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.40 and a quick ratio of 1.40. The stock has a market capitalization of $7.60 billion, a P/E ratio of 224.28, a price-to-earnings-growth ratio of 1.33 and a beta of 1.52. Molina Healthcare has a 1 year low of $71.07 and a 1 year high of $154.06.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, October 31st. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.65 by $0.90. The firm had revenue of $4.70 billion during the quarter, compared to analysts’ expectations of $4.72 billion. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The firm’s quarterly revenue was down 6.6% on a year-over-year basis. During the same period in the prior year, the business posted ($1.62) EPS. As a group, equities research analysts anticipate that Molina Healthcare will post 7.1 earnings per share for the current fiscal year.
In other news, Director Ronna Romney sold 200 shares of the stock in a transaction dated Tuesday, September 4th. The stock was sold at an average price of $138.11, for a total value of $27,622.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider James Woys acquired 25,000 shares of the business’s stock in a transaction dated Wednesday, September 19th. The stock was purchased at an average cost of $148.79 per share, for a total transaction of $3,719,750.00. Following the completion of the acquisition, the insider now directly owns 17,203 shares of the company’s stock, valued at approximately $2,559,634.37. The disclosure for this purchase can be found here. Over the last quarter, insiders sold 9,717 shares of company stock valued at $1,289,932. 0.65% of the stock is currently owned by company insiders.
Hedge funds have recently made changes to their positions in the company. Arrowgrass Capital Partners US LP acquired a new position in shares of Molina Healthcare in the second quarter valued at about $4,711,000. Glenmede Trust Co. NA grew its holdings in Molina Healthcare by 43,291.3% during the second quarter. Glenmede Trust Co. NA now owns 49,900 shares of the company’s stock worth $4,887,000 after acquiring an additional 49,785 shares during the period. Rhumbline Advisers grew its holdings in Molina Healthcare by 22.4% during the second quarter. Rhumbline Advisers now owns 104,482 shares of the company’s stock worth $10,233,000 after acquiring an additional 19,093 shares during the period. Epoch Investment Partners Inc. grew its holdings in Molina Healthcare by 32.7% during the second quarter. Epoch Investment Partners Inc. now owns 354,562 shares of the company’s stock worth $34,726,000 after acquiring an additional 87,460 shares during the period. Finally, Federated Investors Inc. PA grew its holdings in Molina Healthcare by 73.0% during the second quarter. Federated Investors Inc. PA now owns 137,064 shares of the company’s stock worth $13,423,000 after acquiring an additional 57,844 shares during the period.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: Google Finance
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.